Adline Chem Lab logo

Adline Chem Lab share price

BSE: 524604Pharmaceuticals & Biotechnology

ADLINE CHEM LAB LIMITED · Face value ₹10 · Listed Aug 1994

Trading suspended since 13 Oct 2026

Last traded ₹15.79 on 12 Oct 2026

Latest announcements

Routine notices left out.

Share price history

Daily closes since Oct 2016, adjusted for splits and bonuses

−7.4%over a year · Nifty 500 −5.8%

20-session average 770 shares a session, over sessions from 18 Aug 2026 to 12 Oct 2026

Q1 results, quarter to Jun 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

Revenue
₹0.00 Cr
Operating profit
−₹0.04 Cr
Net profit
₹0.04 Cr
Earnings per share
₹0.07

From revenue to net profit, ₹ crore

  1. Revenue0.0
  2. Employee costs0.0
  3. Other expenses0.0
  4. Operating profit0.0
  5. Depreciation0.0
  6. Other income+0.1
  7. Finance costs0.0
  8. Profit before tax0.0
  9. Tax0.0
  10. Net profit0.0

Adline Chem Lab results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends. Every company's dates are on the results calendar.

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss
00.0Sep 2300.0Dec 2300.0Mar 240−0.1Jun 240−0.1Sep 240−0.1Dec 2400.2Mar 250−0.1Jun 250−0.1Sep 250−0.1Dec 250−0.1Mar 2600.0Jun 26
Peak revenue ₹0.00 Cr, quarter to Sep 2023Back to profit in the quarter to Jun 2026, ₹0.04 Cr

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreSep 2021Dec 2021Q3Mar 2022Jun 2022Q1Sep 2022Dec 2022Q3Mar 2023Filed 30 MayJun 2023Q1Filed 14 AugSep 2023Dec 2023Q3Mar 2024Jun 2024Q1Sep 2024Dec 2024Q3Mar 2025Q4Jun 2025Q1Sep 2025Q2Dec 2025Q3Filed 10 FebMar 2026Q4Filed 29 MayJun 2026Q1Filed 13 Aug
Revenue from operations0.000.080.020.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
0.180.090.120.010.290.410.090.080.030.000.060.100.070.100.060.030.050.030.070.04
Materials and goods bought0.000.030.000.000.260.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Employee costs0.090.010.020.020.010.010.010.020.010.010.010.040.050.050.050.010.000.010.000.01
Other expenses0.090.050.090.000.020.400.080.060.020.000.050.070.020.050.010.020.050.020.070.03
Operating profit before depreciation−0.180.00−0.10−0.01−0.29−0.41−0.09−0.08−0.030.00−0.06−0.10−0.07−0.10−0.06−0.03−0.05−0.03−0.07−0.04
Operating margin−19,600.0%−3.2%−475.9%–––––––––––––––––
Depreciation and amortisation0.260.26−0.420.090.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Other income0.160.050.020.000.530.390.070.000.000.000.030.000.000.000.250.000.000.000.010.12
Finance costs0.000.000.000.000.000.000.000.000.000.000.000.030.030.030.030.030.030.040.040.05
Profit before one-off items and tax−0.27−0.210.34−0.100.25−0.02−0.01−0.08−0.030.00−0.04−0.13−0.10−0.130.16−0.06−0.08−0.07−0.110.03
One-off items0.000.001.140.00−4.350.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax−0.27−0.211.48−0.10−4.10−0.02−0.01−0.08−0.030.00−0.04−0.13−0.10−0.130.16−0.06−0.08−0.07−0.110.03
0.000.000.000.000.000.000.000.000.000.000.00−0.01−0.01−0.01−0.05−0.01−0.01−0.01−0.01−0.01
Tax rate––0.0%––––––17.9%––––−29.5%––––−25.3%
Net profit−0.27−0.211.48−0.10−4.10−0.02−0.01−0.08−0.030.00−0.04−0.13−0.09−0.120.21−0.05−0.07−0.06−0.090.04
Other comprehensive income0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Total comprehensive income−0.27−0.211.48−0.10−4.10−0.02−0.01−0.08−0.030.00−0.04−0.13−0.09−0.120.21−0.05−0.07−0.06−0.100.04
Net margin−30,322.2%−249.6%7,296.6%–––––––––––––––––
Earnings per share−₹0.47−₹0.35₹2.53−₹0.17−₹7.01−₹0.04−₹0.02−₹0.14−₹0.05₹0.01−₹0.06–−₹0.02−₹0.02₹0.04−₹0.01−₹0.01–−₹0.17₹0.07
Earnings per share in rupees, restated for later splits and bonuses.

The quarter to Jun 2024 was restated in the company's filing of 14 Nov 2024. The table shows the restated figures.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
170.0Mar 178.20.0Mar 185.60.05.4Mar 196.6−3.62.9Mar 206.3−1.32.5Mar 210.70.71.3Mar 220−4.21.3Mar 230−0.11.5Mar 240−0.11.5Mar 250−0.31.8Mar 26
Peak revenue ₹17 Cr, year to Mar 2017; lowest ₹0.00 Cr, year to Mar 2023A loss in 6 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin
97.5%−54.1%7.1%10.6%10.5%−50.6%−3.6%−40.2%0.1%0.0%0.5%−54.1%−20.3%97.5%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.0
  2. Employee costs0.0
  3. Other expenses−0.1
  4. Operating profit−0.2
  5. Depreciation0.0
  6. Other income0.0
  7. One-off items0.0
  8. Finance costs−0.2
  9. Profit before tax−0.3
  10. Tax0.0
  11. Net profit−0.3

What the company owns

  • Cash and bank₹0 Cr
  • Plant, investments and other assets₹0 Cr

What pays for it: net worth and liabilities

  • Borrowings₹2 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 30 MayMar 2024Mar 2025Mar 2026Filed 29 MayJun 2026Twelve monthsFiled 13 Aug
Revenue from operations17.28.25.66.66.30.70.00.00.00.00.0
16.07.35.09.96.61.00.80.20.30.20.2
Materials and goods bought12.84.61.44.93.00.50.30.00.00.00.0
Employee costs1.31.41.51.91.70.20.10.00.20.00.0
Other expenses1.91.32.13.11.80.40.50.10.10.10.2
Operating profit before depreciation1.20.90.6−3.3−0.2−0.3−0.8−0.2−0.3−0.2−0.2
Operating margin7.1%10.6%10.5%−50.6%−3.6%−40.2%–––––
Materials, % of revenue74.2%56.4%25.5%74.0%47.9%65.2%–––––
Employee costs, % of revenue7.7%17.0%27.1%29.5%27.1%25.1%–––––
Other expenses, % of revenue11.0%16.0%36.9%47.1%28.6%50.0%–––––
Depreciation and amortisation1.00.70.70.41.00.40.10.00.00.00.0
Operating profit after depreciation0.30.1−0.1−3.8−1.3−0.6−0.9−0.2−0.3−0.2−0.2
Other income0.10.20.20.00.00.21.00.00.20.00.1
Finance costs0.30.30.10.00.00.00.00.00.10.20.2
Profit before one-off items and tax0.00.00.0−3.8−1.3−0.40.1−0.1−0.2−0.3−0.2
One-off items––0.00.20.01.1−4.30.00.00.00.0
Profit before tax0.00.00.0−3.6−1.30.7−4.2−0.1−0.2−0.3−0.2
0.00.00.00.00.00.00.00.0−0.10.00.0
Net profit0.00.00.0−3.6−1.30.7−4.2−0.1−0.1−0.3−0.2
Other comprehensive income––0.00.00.00.00.00.00.00.00.0
Total comprehensive income––0.0−3.6−1.30.7−4.2−0.1−0.1−0.3−0.2
Net margin0.1%0.0%0.5%−54.1%−20.3%97.5%–––––

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 30 MayMar 2024Mar 2025Mar 2026Filed 29 May
7.03.51.92.6−1.6−1.7−1.5−1.8
Share capital5.95.95.95.95.95.95.95.9
Reserves1.2−2.4−3.9−3.2−7.4−7.6−7.3−7.6
5.42.92.51.31.31.51.51.8
14.53.83.31.91.31.50.00.0
0.30.40.40.30.30.31.51.8
Total assets21.87.65.64.90.10.00.10.1
12.04.83.74.40.00.00.00.0
9.82.82.00.40.10.00.10.1
Net debt5.22.82.71.31.21.41.41.7
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Filed 30 MayMar 2024Mar 2025Mar 2026Filed 29 May
0.060.210.01−0.02−0.23−0.16
0.060.210.01−0.02−0.33−0.16
0.290.28−0.180.13−0.270.02
Receivables−0.151.510.070.000.000.00
Inventories0.700.130.260.000.000.00
Payables−0.320.21−0.600.130.000.00
Other working capital0.06−1.580.080.00−0.270.02
Tax paid0.000.000.000.000.100.00
Capital spending0.010.000.000.000.000.00
Free cash flow0.050.210.01−0.02−0.23−0.16
0.120.000.000.000.000.00
−0.39−0.010.000.000.250.16
Dividends paid0.000.000.000.000.000.00
Shares bought back0.000.000.000.000.000.00
Shares issued0.000.000.000.000.000.00
Net change in cash−0.210.200.01−0.020.020.00
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 30 MayMar 2024Mar 2025Mar 2026Filed 29 May
Earnings per share₹0.01–₹0.05−₹6.10−₹2.19₹1.23−₹7.24−₹0.25−₹0.02−₹0.48
Diluted earnings per share₹0.01–₹0.05−₹6.10−₹2.19₹1.23−₹7.24−₹0.25−₹0.02−₹0.48
Book value per share––₹12.02₹5.93₹3.30₹4.53−₹2.68−₹2.93−₹2.55−₹3.03
Shareholder yield––––0.0%0.0%0.0%–0.0%0.0%
Market cap at the year end (₹ crore)9.653.984.103.172.983.843.16–7.767.31

Ratios

Standalone, years to March.

RatioMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 30 MayMar 2024Mar 2025Mar 2026Filed 29 May
Revenue growth–−52.5%−31.5%17.8%−4.0%−88.4%−100.0%–––
Operating profit growth–−29.1%−31.9%–––––––
Net profit growth–−77.8%1,280.0%–––––––
––0.4%−67.9%−47.6%31.4%––––
–––−68.3 pts20.4 pts78.9 pts––––
From the net margin–––−43.4 pts42.5 pts276.1 pts––––
From asset turnover–––−32.2 pts−29.0 pts−195.1 pts––––
From borrowing–––7.4 pts6.9 pts−2.1 pts––––
Return on capital employed––−1.2%−59.5%−28.3%−16.3%–––−536.4%
Cash conversion–––––29.4%––––
Interest cover0.80.4––––––––
Debt to equity––0.760.821.300.50––––
Receivable days––136799135––––
Inventory days––83082471970–––
Payable days––434422834064–––
Cash conversion cycle, days––531119110−108––––
Working capital days––3210077−111––––
Asset turnover––0.260.450.960.140.000.000.000.00
Assets per rupee of net worth––3.112.802.452.294.56−0.03−0.04−0.04
Sales per rupee of plant––0.4956.38––––––
Capital spending to depreciation––––0.010.000.00–––
Interest cover is left blank for the years to Mar 2019, Mar 2020, Mar 2021, Mar 2022, Mar 2025 and Mar 2026: operating profit after depreciation is a loss, and a loss covers no interest bill. Debt to equity is left blank for the years to Mar 2023, Mar 2024, Mar 2025 and Mar 2026: net worth is below zero, so there is no shareholders' money to set the borrowings against. Return on capital employed is left blank for the years to Mar 2023, Mar 2024 and Mar 2025: net worth and borrowings together come to nought or less, so there is no money employed to set the operating profit against. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
−388.8%
Measure5 years3 years
Asset turnover, average0.030.00

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−0.18−0.40−0.16
Cash from investing0.000.000.00
Cash from financing0.400.410.16
Capital spending0.000.000.00
Dividends paid0.000.000.00
Shares bought back0.000.000.00
Shares issued for cash0.000.000.00
Borrowings raised0.660.660.28
Borrowings repaid0.000.000.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––54––––
Altman Z-scorePublished threshold 1.81–––––0.39−418.43–––
Beneish M-scorePublished threshold −1.78––––−3.77−2.86––––
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––−22.099.64−172.24−244.66159.56−169.85
Receivables growth less revenue growthOur threshold 0 percentage points–––−49.0914.61−7.140.00–––
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––−308.52−26.2750.21−53.97–––
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−63.180.01−13.63––––
Assets under construction, years of additionsOur threshold 2 years of additions––––0.000.000.00–––
Effective tax ratePublished threshold 17.16 per cent35.7192.869.21––0.00––––
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––0.00––––
A threshold marked as ours has no published figure; it is the line we read the check against.

Business segments

In the year to Mar 2026 the company reports one business segment, Pharmaceuticals, which carries all its revenue.

Where the return came from

Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.

OverReturn a yearEarnings growthChange in P/EDividend yield
1 year−5.7%––0.0%
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1 year is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.

Who owns Adline Chem Lab, filing by filing

Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.

Sep 2026 filing

  • Promoters25.85%
  • Individuals and others74.15%

Shareholding pattern, per cent, from Sep 2022

  • Promoters
  • Individuals and others
74.15%25.85%25.85%74.15%Sep 22Jun 23Mar 24Dec 24Sep 25Sep 26
Per centDec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
33.24%33.24%33.24%33.24%33.24%33.24%33.24%31.53%31.18%31.46%31.46%31.46%31.46%31.46%31.46%31.46%31.46%31.46%31.46%30.45%30.17%30.17%30.17%28.24%28.24%28.24%28.24%28.24%28.24%29.61%29.61%29.61%29.61%29.61%25.85%29.61%25.85%25.85%25.85%25.85%
Indian promoters33.24%33.24%33.24%33.24%33.24%33.24%33.24%31.53%31.18%31.46%31.46%31.46%31.46%31.46%31.46%31.46%31.46%31.46%31.46%30.45%30.17%30.17%30.17%28.24%28.24%28.24%28.24%28.24%28.24%29.61%29.61%29.61%29.61%29.61%25.85%29.61%25.85%25.85%25.85%25.85%
66.76%66.76%66.76%66.76%66.76%66.76%66.76%68.47%68.82%68.54%68.54%68.54%68.54%68.54%68.54%68.54%68.54%68.54%68.54%69.55%69.83%69.83%69.83%71.76%71.76%71.76%71.76%71.76%71.76%70.39%70.39%70.39%70.39%70.39%74.15%70.39%74.15%74.15%74.15%74.15%
Shares in issue58,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,00058,50,000
Shares locked in19,44,250–––––––––––––––––––––––––––––––––––––––
Promoters' shares locked in19,44,250–––––––––––––––––––––––––––––––––––––––
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

Number of Adline Chem Lab shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

18,783Dec 1618,765Mar 1718,767Jun 1718,763Sep 1718,756Dec 1718,756Mar 1818,739Jun 1818,741Sep 1818,736Dec 1818,723Mar 1918,729Jun 1918,723Sep 1918,715Dec 1918,717Mar 2018,712Jun 2018,707Sep 2018,706Dec 2018,705Mar 2118,704Jun 2118,704Sep 2118,700Dec 2118,695Mar 2218,689Jun 2218,686Sep 2218,678Dec 2218,670Mar 2318,661Jun 2318,638Sep 2318,628Dec 2318,595Mar 2418,584Jun 2418,536Sep 2418,509Dec 2418,514Mar 2518,493Jun 2518,488Sep 2518,468Dec 2518,446Mar 2618,444Jun 2618,433Sep 26
ShareholdersDec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
All shareholders18,78318,76518,76718,76318,75618,75618,73918,74118,73618,72318,72918,72318,71518,71718,71218,70718,70618,70518,70418,70418,70018,69518,68918,68618,67818,67018,66118,63818,62818,59518,58418,53618,50918,51418,49318,48818,46818,44618,44418,433
202020202020202019191919191919191919191413131311111111111199999191111
Indian promoters202020202020202019191919191919191919191413131311111111111199999191111
18,76318,74518,74718,74318,73618,73618,71918,72118,71718,70418,71018,70418,69618,69818,69318,68818,68718,68618,68518,69018,68718,68218,67618,67518,66718,65918,65018,62718,61718,58618,57518,52718,50018,50518,49218,47918,46718,44518,44318,432
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

Adline Chem Lab promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Hemant Amrish Parikh, 25.85%.

Holder
Hemant Amrish ParikhIndividuals and Hindu undivided families25.85%15,12,440
No promoter shares are reported as pledged.

Largest public holders of Adline Chem Lab, filing by filing

Per cent, on the same shares as the split above.

HolderDec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sonal R BambhaniaResident individuals, over ₹2 lakh at face value1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%1.14%–––1.14%–1.14%1.14%1.14%1.14%1.14%1.14%
Yash Kashyap MehtaResident individuals, over ₹2 lakh at face value––––––––1.61%1.59%1.55%1.54%1.54%1.53%1.53%1.53%1.53%1.52%1.51%1.51%1.50%1.49%1.48%1.46%1.43%1.41%––––––––––––––
Yash K MehtaResident individuals, over ₹2 lakh at face value–––––––1.71%––––––––––––––––––––––––––––––––
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.

Adline Chem Lab share price by year

Each calendar year to 2025.

YearClose at year endChangeHighest closeLowest close
20259.21−58.6%21.147.60
202422.25−16.9%28.9712.50
202326.79+387.1%27.335.15
20225.50−25.8%11.375.50
20217.41+48.2%7.415.04
20205.00−12.3%5.505.00
20195.70−2.1%7.235.51
20185.82−20.1%7.505.29
20177.28−52.6%18.157.28
201615.35–21.1012.50
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2021 is from its first session, 21 Jan 2021. 2020 is from its first session, 16 Mar 2020. 2019 is from its first session, 18 Jan 2019. 2016 is from its first session, 27 Oct 2016. The close is the year's last trade for 2023 (19 Dec 2023), 2020 (14 Nov 2020), 2019 (5 Nov 2019) and 2017 (23 Nov 2017).

Recent sessions

The 10 trading days to 12 Oct 2026, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
12 Oct 202615.7915.7915.7915.7915.792,500
5 Oct 202615.7915.7915.7915.7915.79500
24 Sep 202615.0415.0415.0415.0415.04400
23 Sep 202614.3314.3314.3314.3314.33100
22 Sep 202613.6513.6513.6513.6513.65400
17 Sep 202613.0013.0013.0013.0013.00100
16 Sep 202612.6012.6012.6012.6012.60200
15 Sep 202612.0012.0912.0012.0912.095,800
9 Sep 202611.5211.5211.5211.5211.52400
3 Sep 202612.1212.1212.1212.1212.12500
Prices in ₹ per share as traded, not adjusted.

Company details

BSE code
524604
ISIN
INE276T01018
Industry
Pharmaceuticals & Biotechnology
CIN
L24231GJ1988PLC010956
Corporate identity number, the registrar of companies' code for it
Incorporated
1988
Registered office
403, Sarthik II, Opp. Rajpath Club, S.G.Highway, Bodakdev, Ahmedabad 380054, Gujarat
Share registrar
MUFG Intime India Pvt. Ltd
Keeps the register of shareholders and handles transfers and dividend payments